Rice Hall James & Associates, LLC Akebia Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

$1.63 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.32 - $0.67 $164,253 - $343,905	-513,292 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$0.72 - $2.93 $19,491 - $79,320	27,072 Added 5.57%	513,292 $368,000
Q4 2021 Feb 14, 2022	SELL	$2.26 - $3.34 $180,361 - $266,552	-79,806 Reduced 14.1%	486,220 $1.1 Million
Q3 2021 Nov 09, 2021	BUY	$2.35 - $3.88 $30,667 - $50,634	13,050 Added 2.36%	566,026 $1.63 Million
Q2 2021 Jul 29, 2021	SELL	$2.83 - $4.2 $70,738 - $104,983	-24,996 Reduced 4.32%	552,976 $2.1 Million

Q1 2021 May 14, 2021	SELL	$2.92 - $5.06 $2.83 Million - $4.9 Million	-968,197 Reduced 62.62%	577,972 $1.96 Million
Q4 2020 Feb 16, 2021	SELL	$2.22 - $3.78 $73,060 - $124,399	-32,910 Reduced 2.08%	1,546,169 $4.33 Million
Q3 2020 Nov 16, 2020	BUY	$2.39 - $13.08 $492,796 - $2.7 Million	206,191 Added 15.02%	1,579,079 $3.96 Million
Q2 2020 Aug 14, 2020	SELL	$6.67 - $13.58 $228,620 - $465,468	-34,276 Reduced 2.44%	1,372,888 $18.6 Million
Q1 2020 May 15, 2020	BUY	$4.1 - $10.24 $35,026 - $87,480	8,543 Added 0.61%	1,407,164 $10.7 Million
Q4 2019 Jan 29, 2020	SELL	$3.16 - $6.73 $270,230 - $575,522	-85,516 Reduced 5.76%	1,398,621 $8.84 Million
Q3 2019 Oct 30, 2019	SELL	$3.55 - $5.4 $35,262 - $53,638	-9,933 Reduced 0.66%	1,484,137 $5.82 Million
Q2 2019 Aug 01, 2019	SELL	$4.1 - $8.05 $211,609 - $415,476	-51,612 Reduced 3.34%	1,494,070 $7.23 Million
Q1 2019 May 01, 2019	BUY	$5.41 - $8.73 $1.75 Million - $2.83 Million	324,184 Added 26.54%	1,545,682 $12.7 Million
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $6.37 Million - $10.8 Million	1,181,278 Added 2937.04%	1,221,498 $6.76 Million
Q3 2018 Oct 25, 2018	BUY	$7.44 - $10.65 $299,236 - $428,343	40,220 New	40,220 $355,000

Others Institutions Holding AKBA

# of Institutions

127

Shares Held

56.7M

Call Options Held

937K

Put Options Held

743K

Satter Management Co., L.P.

13.2M
Shares

$13.5 Million
26.98% of portfolio
Vanguard Group Inc Valley Forge, PA

8.23M
Shares

$8.39 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

5.31M
Shares

$5.42 Million
0.03% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.65M
Shares

$3.73 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.27M
Shares

$3.33 Million
0.0% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $188M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account